GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (ASX:RHY) » Definitions » Book Value per Share

Rhythm Biosciences (ASX:RHY) Book Value per Share : A$0.01 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Rhythm Biosciences Book Value per Share?

Rhythm Biosciences's book value per share for the quarter that ended in Dec. 2023 was A$0.01.

During the past 12 months, Rhythm Biosciences's average Book Value Per Share Growth Rate was -88.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -27.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -27.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Rhythm Biosciences was 17.60% per year. The lowest was -51.50% per year. And the median was -20.00% per year.

Rhythm Biosciences's current price is A$0.089. Its book value per share for the quarter that ended in Dec. 2023 was A$0.01. Hence, today's PB Ratio of Rhythm Biosciences is 29.67.

During the past 7 years, the highest P/B Ratio of Rhythm Biosciences was 249.38. The lowest was 0.00. And the median was 0.00.


Rhythm Biosciences Book Value per Share Historical Data

The historical data trend for Rhythm Biosciences's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Biosciences Book Value per Share Chart

Rhythm Biosciences Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Book Value per Share
Get a 7-Day Free Trial 0.02 0.01 0.03 0.03 -

Rhythm Biosciences Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.04 0.03 0.01 -

Competitive Comparison of Rhythm Biosciences's Book Value per Share

For the Diagnostics & Research subindustry, Rhythm Biosciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhythm Biosciences's PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rhythm Biosciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where Rhythm Biosciences's PB Ratio falls into.



Rhythm Biosciences Book Value per Share Calculation

Rhythm Biosciences's Book Value Per Share for the fiscal year that ended in Jun. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(0.87-0.00)/248.60
=0.00

Rhythm Biosciences's Book Value Per Share for the quarter that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1.24-0.00)/225.88
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Rhythm Biosciences  (ASX:RHY) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Rhythm Biosciences Book Value per Share Related Terms

Thank you for viewing the detailed overview of Rhythm Biosciences's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Rhythm Biosciences Business Description

Traded in Other Exchanges
N/A
Address
30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. The company operates predominantly in one business and geographical segment which is the research and development of biosciences in Australia.

Rhythm Biosciences Headlines

No Headlines